Please enable JavaScript.
Coggle requires JavaScript to display documents.
Malaria chemoprofilaxis - Coggle Diagram
Malaria chemoprofilaxis
Risk assessment 
-
Couseling
-
-
-
Clinical escenarios
-
-
The chemoprophylactic regimen can be followed with the local regimen as long as there are no drug interactions or it is contraindicated.
In rapid negative tests, these should be repeated twice at intervals of 12-24 hours.
Chemoprofilaxis
Suggestions
-
In patients with multiple destinations, the selection of a single agent effective in the entire exposure is effective.
Scenarios
In low-risk malaria destinations, chemoprophylaxis is not necessary
In areas at risk of chloroquine-resistant malaria, chemiprophylaxis and measures to prevent mosquito bites are used
Consideraciones
Prophylaxis with atovaquone-proguanil, mefloquine, doxycycline and tafenoquine
-
-
-
In areas where P.vivax predominates, chemoprophylaxis and measures against mosquito bites are recommended.
-
-
On short trips, atovaquone-proguanil may be preferred.
Special populations
Pregnant women
-
In areas where malaria sensitive to chloroquine exists, prophylaxis and mosquito bite control measures are used.
Atovaquone-proguanil, primaquine and tafenoquine should not be administered during pregnancy.
Doxycycline in some countries is allowed until the 15th week of pregnancy, although it is preferred to avoid its administration.
Children
-
-
In children who cannot swallow pills, they can be crushed and mixed with drinks and food.